Pharmacovigilance: Boon for the safety and efficacy of ayuvedic formulations

Journal of Ayurveda and Integrative Medicine

Volumn 1, Issue 4, 2010, Pages 251-256

  Chaudhary, Anand ^a,b   Singh, Neetu ^b   Kumar, Neeraj ^b  

^a BANARAS HINDU UNIVERSITY   (India)

^b BANARAS HINDU UNIVERSITY   (India)

Author keywords

Adverse drug reaction; Awareness; Ayurvedic medicine; Pharmacovigilance; Safety

Indexed keywords

AYURVEDIC DRUG;

ARTICLE; AYURVEDA; DRUG EFFICACY; DRUG FORMULATION; DRUG PROGRAM; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; HEALTH PROMOTION; HUMAN; PATIENT CARE; PHARMACOEPIDEMIOLOGY; PRIORITY JOURNAL; PUBLIC HEALTH; TRADITIONAL MEDICINE;

EID: 79952910447     PISSN: 09759476     EISSN: 09762809     Source Type: Journal    
DOI: 10.4103/0975-9476.74427     Document Type: Article

References (24)

1. Satkopan S. Quality Control and Standardisations of Ayurvedic Medicines, Proceedings of National Workshop for Internationally Acceptable Protocol of Ayurvedic Formulations, IPGTRA, Gujarat Ayurveda University, Jamnagar; 2000.
2. Available from: http://www.ayukalp.com/what-is-ayurveda. html [Last accessed on 2010 Apr 20].
3. Saper RB, Phillips RS, Sehgal A, Khouri N, Davis RB, Paquin J, Lead, mercury, and arsenic in US- and Indian manufactured Ayurvedic medicines sold via the Internet. JAMA 2008;300:915-23.
4. Chaudhary A. Power point presentation at CME on Pharmacovigilance of Ayurvedic Drugs at State Ayurvedic College, Lucknow 2008.
5. The importance of Pharmacovigilance-Safety Monitoring of Medicinal Products, WHO, and medicine WHO guideline on safety monitoring of herbal medicines in pharmacovigilance system. Available from: http://www.whoindia.org/ LinkFiles/ Traditional [last accessed on 2002].
6. Bhaleroa S, Thatte U. Proceedings of Pre conference workshop "Pharamacovigilance of Ayurvedic Medicines", 2006.
7. Effective communications in Pharmacovigilance. The Erice Report. International Conference on developing effective communications in pharmacovigilance, Erice, Sicily, 1997.
8. Available from: http://www.cdsco.nic.in/html/pharmaco. html [Last accessed on 2010 Apr 20].
9. Sten O. Pharmacovigilance training with focus on India, Indian J Pharmacol 2008;40:S28-S30
10. Kulkarni RD. Reporting system for rare side effects of non narcotic analgesics in India: Problems and Opportunities. Med Toxicl 1986;1:110-3. (Pubitemid 17013553)
11. Arora D. Pharmacovigilance obligations of the pharmaceuticals companies, Indian J Pharmacol 2008:40:S13-S16.
12. Available from: http/www.cdsco.nic.in/home page / Pharmacovigilance protocol/list of all centre/ [Last accessed on 2010].
13. Available from: http/www.phamexcil.org/pharma in media [Last accessed on 2010 Apr 20].
14. Anonymous. WHO Traditional Medicine Strategy 2002- 2005. Geneva: WHO; 2002.
15. Thatte U. Proceedings of Pre conference workshop "Pharamacovigilance of Ayurvedic Medicines", 2006.
16. Chaudhary AK (Organising Secretary), Technical Report, WHO sponsored Seminar cum Workshop on Safety Profile of Ayurvedic Dosage Forms; 2007.
17. Galib M, Acharya R. National Pharmacovigilance Programme for Ayurveda,Siddha and Unani Drugs,AYU; 2008;29;4; 191-193.
18. Anonymus National Pharmacovigilance Protocol for ASU Drugs, IPGTRA. Gujarat Ayurveda Unversity; 2008.
19. Available from: http://www.whoindia.org/LinkFiles/Traditional Medicine National Pharmacovigilance Protocol for Ayurveda Siddha Unani Drugs.pdf [Last accessed on 2010 Apr 20].
20. Available from: http://ayurveduniversity.com/pharmococell. php [Last accessed on 2010 Apr 20].
21. Dalvi SS, Nayak VK, Pohujani SM, Desai NK, Kshirsagar NA, Gupta KC. Effect of gugulipid on bioavailability of diltiazem and propranolol. J Assoc Physicians India 1994;42:454-5.
22. Shastri K, Chaturvedi GN. Charark Samhita, Sutra Sthana. Vol. 26. Vidyotini Hindi Commentary. Varanasi;: Chaukhamba Bharati Academy; 2002. p. 82-4.
23. Available from: http://www.indianmedicine.nic.in/notifications. asp [Last accessed on 2010 Apr 20].
24. Pipasha B. Setting Standards for proactive Pharmacovigilance in India: The way Forward. Indian J Pharmacol 2007;39: 124-8.